Meridiem Capital Partners LP bought a new position in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 11,774 shares of the company's stock, valued at approximately $1,476,000. Meridiem Capital Partners LP owned approximately 0.06% of Addus HomeCare as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of the stock. Natixis lifted its stake in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its stake in Addus HomeCare by 324.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust lifted its stake in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new stake in Addus HomeCare during the 4th quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in Addus HomeCare during the 4th quarter valued at approximately $86,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Stock Performance
Shares of NASDAQ ADUS opened at $110.55 on Tuesday. The firm has a market cap of $2.03 billion, a PE ratio of 25.30, a PEG ratio of 1.41 and a beta of 0.85. The firm has a fifty day moving average of $99.15 and a 200 day moving average of $114.14. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the prior year, the firm earned $1.21 earnings per share. The company's revenue for the quarter was up 20.3% compared to the same quarter last year. On average, equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Analysts Set New Price Targets
Several analysts have commented on the stock. Stephens restated an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. JMP Securities restated a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Macquarie lifted their price objective on shares of Addus HomeCare from $129.00 to $133.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, Oppenheimer boosted their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $142.57.
Check Out Our Latest Analysis on ADUS
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
